日本皮膚科学会アトピー性皮膚炎治療ガイドライン2004改訂版

書誌事項

タイトル別名
  • Guidelines for Therapy for Atopic Dermatitis 2004
  • 生涯教育講座 日本皮膚科学会アトピー性皮膚炎治療ガイドライン2004改訂版
  • ショウガイ キョウイク コウザ ニホン ヒフ カガクカイ アトピーセイ ヒフエン チリョウ ガイドライン 2004 カイテイバン

この論文をさがす

抄録

Recently in Japan, misunderstandings about the pathogenesis of atopic dermatitis (AD) and the strategies for the treatment of this disease, especially about the use of topical steroid, have led to a rapid increase of severe cases of AD caused by inadequate treatment. This prompted us to establish and distribute standard guidelines for AD therapy. In this guideline, the necessity of dermatological training to examine severe cases of AD is emphasized. It is stated that the present standard therapies for AD consist of the use of topical steroid and tacrolimus ointment for inflammation and emollient for dry and barrier-disrupted skin as the first line of attack, anti-histamines and anti-allergic drugs for pruritus, avoidance of apparent exacerbating factors, psychological counseling, and advice about daily life. Tacrolimus ointment was used initially only for adult patients and recently low density ointment is available for 2-15year old patients. The importance of correct selection of topical steroid according to the severity of the lesion is emphasized.

収録刊行物

被引用文献 (56)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ